JG

John L. Gilmore

BS Bristol-Myers Squibb: 28 patents #139 of 3,969Top 4%
WC Warner-Lambert Company: 3 patents #488 of 1,610Top 35%
Basf Se: 1 patents #8,065 of 13,826Top 60%
📍 Yardley, PA: #37 of 643 inventorsTop 6%
🗺 Pennsylvania: #1,721 of 74,527 inventorsTop 3%
Overall (All Time): #115,377 of 4,157,543Top 3%
31
Patents All Time

Issued Patents All Time

Showing 26–31 of 31 patents

Patent #TitleCo-InventorsDate
7253283 Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof David S. Weinstein, James Sheppeck, Bingwei Yang, Soong-Hoon Kim, Wayne Vaccaro 2007-08-07
7211671 Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) James Sheppeck, Xiao-Tao Chen, Xiaohua He 2007-05-01
7074810 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme Bryan Wayne King, James Sheppeck 2006-07-11
6001331 Method of imaging amyloid deposits Bradley W. Caprathe, Sheryl Jeanne Hays, Juan C. Jaen, Harry LeVine, III 1999-12-14
5919790 Hydroxamate inhibitors of interleukin-1.beta. converting enzyme Hamish Allen, Kenneth Dale Brady, Bradley W. Caprathe, Paul Galatsis, Sheryl Jeanne Hays +3 more 1999-07-06
5652237 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes Corinne E. Augelli-Szafran, Bradley W. Caprathe, Sheryl Jeanne Hays, Juan C. Jaen, Jan Ruth Penvose-Yi 1997-07-29